E Cannabis Central: Pure-Play Pot Stock Index Up Marginally On Thursday

Herb, Hemp, Plant, Cab, Cannabinoid

Image Source: Pixabay
 

The munKNEE.com Pot Stock Index of the 25 pure-play* cannabis stocks that trade for more than US$1/share advanced 0.8% on Thursday but with only 4 constituents advancing. As a result, 2 of the 4 industry categories declined as well. The details are as follows:

4 constituents advanced by 5% or more, namely:

  1. Ayr Strategies (AYRSF) +11.0% (rebounding from yesterday's disappointing Q2 results as reported here)
  2. Columbia Care (CCHWF) +7.0% (announced acquisition of Colorado-based The Green Solution)
  3. TerrAscend (TRSSF) +6.7%
  4. Neptune Wellness (NEPT) +5.1%

8 other constituents advanced and 2 remained unchanged in price.

1 constituent declined by 5% or more, namely:

  • Planet 13 (PLNHF) -6.2% (in response to the announcement of a $15M Bought Deal Offering)

10 other constituents declined.

The constituents operate in 4 categories based on their primary area of focus in the cannabis industry and the constituents within each category are identified below with how each of the categories did:

  1. The Vertically Integrated (i.e. Seed-to-Sale) Category consists of 21 companies that grow, process, and sell cannabis and hemp flower and related products and it advanced 0.9%.
    • the 7 constituents that are Canadian Licensed Producers (LPs) advanced 0.3%, on average. They are:
    • the 12 constituents that are U.S. Multi-State Operators (MSOs) advanced 1.3%, on average. They are:
    • the 2 MSO constituents that are only involved in the seed-to-sale of CBD from hemp declined 0.5%, on average. They are:
  2. The Extraction Category consists of companies focused on the extraction of cannabis compounds and their infusion into consumer products and it advanced 1.9%, on average.
    • the 2 constituents in this category are NEPT and VLNCF
  3. The Consumption Devices Category consists of companies focused on developing and selling personal consumption devices for cannabis consumers such as vape pens and inhalers. Its price declined 1.9%.
    • the 1 constituent in this category is GNLN
  4. The Biotechnology Category consists of pharmaceutical companies marketing new drugs and products utilizing cannabinoids (CBD) and the category declined 2.7%.
    • the 1 constituent in this category is AVCNF
1 2
View single page >> |

Visit  munKNEE.com and register to receive our free Market Intelligence Report newsletter (sample  more

How did you like this article? Let us know so we can better customize your reading experience.

Comments

Leave a comment to automatically be entered into our contest to win a free Echo Show.